IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab—pharmacokinetic modeling to optimize therapeutic index

[1]  Rahul S. Yerrabelli.  ryerrabelli/8H9-Model-Essentials-Public: Release of CSF two-compartment modeling code for Omburtamab (8H9) , 2020 .

[2]  J. Humm,et al.  Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors , 2019, The Journal of Nuclear Medicine.

[3]  S. Larson,et al.  Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. , 2018, The Lancet. Oncology.

[4]  J. Humm,et al.  A phase II study of radioimmunotherapy with intraventricular 131I‐3F8 for medulloblastoma , 2018, Pediatric blood & cancer.

[5]  X. Zang,et al.  Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy , 2016, Clinical Cancer Research.

[6]  S. Larson,et al.  Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3* , 2015, The Journal of Biological Chemistry.

[7]  Steven M. Larson,et al.  Radioimmunotherapy of human tumours , 2015, Nature Reviews Cancer.

[8]  J. Humm,et al.  Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy , 2015, Journal of Neuro-Oncology.

[9]  M. Field,et al.  Novel application of acetazolamide to reduce cerebrospinal fluid production in patients undergoing thoracoabdominal aortic surgery. , 2014, Interactive cardiovascular and thoracic surgery.

[10]  Dietmar Rieder,et al.  A novel RB E3 Ubiquitin Ligase (NRBE3) promotes cancer cell proliferation through a regulation loop with RB/E2F1 , 2013 .

[11]  J. Humm,et al.  Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  T. Moger,et al.  Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients , 2010, Pharmacy practice.

[13]  Assawin Gongvatana,et al.  Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[14]  J. Humm,et al.  Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma , 2010, Journal of Neuro-Oncology.

[15]  N. Cheung,et al.  A Pharmacokinetic Model for Radioimmunotherapy Delivered Through Cerebrospinal Fluid for the Treatment of Leptomeningeal Metastases , 2009, Journal of Nuclear Medicine.

[16]  W. Gerald,et al.  Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Supuran,et al.  Carbonic anhydrase inhibitors as anticonvulsant agents. , 2007, Current topics in medicinal chemistry.

[18]  D. Leaf,et al.  Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. , 2007, Journal of applied physiology.

[19]  J. Humm,et al.  Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9. , 2005, Cancer biotherapy & radiopharmaceuticals.

[20]  Volume of brain ventricles in man determined by computer tomography , 2004, Neuroradiology.

[21]  G. Heit,et al.  The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer’s type , 2001, Neurology.

[22]  S. Gultekin,et al.  Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors. , 2001, Cancer research.

[23]  H. Dalton,et al.  Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shunts , 2001, Archives of disease in childhood.

[24]  J. Humm,et al.  Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  J. Kaye,et al.  The Significance of Age‐Related Enlargement of the Cerebral Ventricles in Healthy Men and Women Measured by Quantitative Computed X‐Ray Tomography , 1992, Journal of the American Geriatrics Society.

[26]  J. Kaye,et al.  Cerebrospinal fluid production is reduced in healthy aging , 1990, Neurology.

[27]  N. Cheung,et al.  Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. , 1986, Journal of the National Cancer Institute.